文献速递产科

剖宫产术后镇痛三种方案的比较:一项随机对照试验

Comparison of 3 protocols for analgesia control after cesarean delivery: a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-04-08

该随机对照试验于2017年4月至2018年5月纳入127例择期剖宫产产妇,随机分为固定静脉方案组(n=41)、固定口服方案组(n=43)和按需方案组(n=43),比较术后48小时疼痛视觉模拟评分、镇痛药总剂量及母婴不良结局;固定静脉与固定口服方案较按需方案降低视觉模拟评分,但按需组镇痛药用量更少,各组母婴不良结局无差异。

要点

  • 术后24小时平均视觉模拟评分静脉组6.2±0.8、口服组7.0±1.1、按需组7.5±0.7(P=.01)。
  • 术后48小时总视觉模拟评分静脉组6.4±0.7、口服组6.8±0.9、按需组7.4±0.7(P<.001)。
  • 静脉组较固定口服组平均疼痛评分降幅更高(4.7±1.2 vs 4.0±1.4;P=.02)。

核心结论

  • 剖宫产术后以固定时间间隔给予布洛芬和对乙酰氨基酚(静脉或口服)较按需方案降低视觉模拟评分疼痛评分,尽管按需组镇痛药用量更少。

研究设计与样本

  • 随机对照试验,于2017年4月至2018年5月开展,纳入127例择期剖宫产产妇,随机分为固定静脉方案组(n=41)、固定口服方案组(n=43)和按需方案组(n=43),比较术后48小时镇痛方案。

主要发现

  • 术后24小时平均视觉模拟评分静脉组6.2±0.8、口服组7.0±1.1、按需组7.5±0.7(P=.01);术后48小时总视觉模拟评分分别为6.4±0.7、6.8±0.9、7.4±0.7(P<.001)。
  • 静脉组平均疼痛评分降幅高于固定口服组(4.7±1.2 vs 4.0±1.4;P=.02)。
  • 术后24小时镇痛药剂量中位数静脉组5(四分位距5-7)、口服组6(四分位距4-6)、按需组4(四分位距3-6)(P=.001);术后48小时总剂量中位数分别为9(四分位距7-10)、9(四分位距7-10)、7(四分位距4-9)(P<.001)。
  • 各组新生儿出生体重及母婴不良结局无组间差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proper pain control after cesarean delivery is of high clinical importance to the recovery and relief of patients after surgical delivery. OBJECTIVE: We aimed to compare fixed time interval to on-demand regimens of nonopioid analgesics and to assess whether a protocol that is based on intravenous administration is superior to oral administration. STUDY DESIGN: This was a randomized controlled trial performed between April 2017 and May 2018. Patients who underwent elective cesarean delivery were assigned randomly to receive 1 of 3 pain relief protocols for the first 48 hours after surgery: (1) the fixed intravenous protocol included intravenous paracetamol (acetaminophen) 3 times daily with oral ibuprofen twice daily, (2) the fixed oral protocol included oral paracetamol 3 times daily with oral ibuprofen twice daily; if the patient requested additional analgesia, tramadol hydrochloride or dipyrone were given as rescue treatments, (3) the on-demand protocol included oral paracetamol or ibuprofen or dipyrone (based on visual analog scale). Pain intensity was measured and compared with the use of the visual analog scale (range, 0 ([no pain] to 10 [worst pain]). Total doses of pain relief analgesia and maternal and neonatal adverse effects were compared between the groups. RESULTS: The study included 127 women who were assigned randomly to the intravenous protocol group (n=41), oral protocol group (n=43), and on-demand protocol group (n=43). There were no between group differences in maternal and pregnancy characteristics, cesarean delivery indications, or surgical technique. The average visual analog scale score was 6.2±0.8 in the intravenous group, 7.0±1.1 in the oral group, and 7.5±0.7 in the on-demand group, in the first 24 hours (P=.01) and 6.4±0.7, 6.8±0.9, and 7.4±0.7 for the total 48 hours, respectively (P<.001). Mean pain score reduction was higher in the intravenous protocol compared with the fixed oral protocol group (4.7±1.2 vs 4.0±1.4; P=.02). The median doses of pain relief analgesia in the intravenous group were 5 (interquartile range, 5-7), 6 in the oral group (interquartile range, 4-6), and 4 in the on-demand group (interquartile range, 3-6; P=.001) in the first 24 hours and 9 (interquartile range, 7-10), 9 (interquartile range, 7-10), and 7 (interquartile range, 4-9), respectively, for the total 48 hours (P<.001). There were no "between group" differences in neonatal birthweight or maternal and neonatal adverse outcomes. CONCLUSION: Administration of pain relief analgesia (ibuprofen and acetaminophen) in fixed time intervals (intravenous or oral) after cesarean delivery yielded reduced visual analog scale pain scores compared with an on-demand protocol, despite fewer pain relief drugs consumed in the on-demand group.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Dafna L, Herman HG, Ben-Zvi M, et al. Comparison of 3 protocols for analgesia control after cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol MFM. 2019. PMID: 33345816. doi:10.1016/j.ajogmf.2019.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。